Fortis Healthcare Share Price
Mid Cap | Pharmaceuticals and health care | NSE: FORTIS | BSE: 532843
₹649.45 -10.25 (-1.55 %)
Last Updated: 04 Apr 2025 03:59 PM
Overview
Open (₹) 659.00
High (₹) 661.10
Low (₹) 639.90
Prev. Close (₹) 659.70
Volume 10,80,120
VWAP (₹) 610.82
ROCE (%) 9.52
Industry P/E 96.77
TTM P/E 63.73
P/B Ratio 5.73
Market Cap (₹) Cr.49,030.76
Dividend Yield (%)0.15
EPS (₹) 7.93
ROE7.00%
Sales Growth (%) 9.45
Profit Growth (%)4.02
Day Range
661.10661.10
52 Week Range
406.35744.00
Historical Returns
Returns (6M)
11.96 %
Returns (1Y)
48.67 %
Returns (3Y)
134.46 %
Returns (5Y)
424.6 %
Returns (6M)
11.96 %
Returns (1Y)
48.67 %
Returns (3Y)
134.46 %
Returns (5Y)
424.6 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (1.67%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Company with 1.67% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Increasing Revenue every Quarter for the past 4 Quarters
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Positive ROC (9) indicates upward momentum.
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
RSI 49.05
MFI 36.64
ATR 22.98
Commodity Channel Index -41.59
ROC125 13.72
ROC21 -5.41
Williams %R -65.66
Resistance & Support
Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
---|---|---|---|---|---|---|---|
Current | 620.80 | 628.90 | 637.80 | 611.90 | 603.80 | 594.90 | 586.80 |
Week Ago | 627.61 | 635.88 | 647.16 | 616.33 | 608.06 | 596.78 | 588.51 |
Month Ago | 592.46 | 603.73 | 611.46 | 584.73 | 573.46 | 565.73 | 554.46 |
EMA & SMA
649.45
Current Price
Bullish Moving Averages
18
Bearish Moving Averages
2
5 Day 613.76
9 Day 610.27
10 Day 607.98
12 Day 610.84
14 Day 613.38
20 Day 620.91
26 Day 619.39
50 Day 651.13
100 Day 645.34
200 Day 576.72
Deals & Announcements
Bulk and Block Deals
Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
---|---|---|---|---|---|---|
UBS PRINCIPAL CAPITAL ASIA LIMITED | block | Sell | 23 Jan, 2025 | ₹638.65 | 25,75,203 | NSE |
UBS AG | block | Buy | 23 Jan, 2025 | ₹638.65 | 25,75,203 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 14 Nov, 2022 | ₹282.25 | 5,93,464 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 14 Nov, 2022 | ₹282.25 | 5,93,464 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Nov, 2022 | ₹280.25 | 5,93,464 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Nov, 2022 | ₹280.25 | 5,93,464 | NSE |
ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹264.20 | 88,770 | NSE |
ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹264.20 | 6,38,068 | NSE |
ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹264.20 | 88,770 | NSE |
ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹264.20 | 6,38,068 | NSE |
RARE ENTERPRISES | bulk | Sell | 18 Mar, 2021 | ₹184.65 | 86,00,000 | NSE |
JHUNJHUNWALA RAKESH | bulk | Buy | 18 Mar, 2021 | ₹184.65 | 86,00,000 | NSE |
WF ASIAN SMALLER COMPANIES FUND LIMITED | bulk | Sell | 02 Nov, 2020 | ₹125.67 | 40,50,000 | NSE |
Insider Trading
Date | Name | Action | Avg. Price | Quantity | Deal Value |
---|---|---|---|---|---|
23 Feb, 2021 | Ashish Bhatia | Disposal | ₹159.00 | 34,415 | NSE |
20 Feb, 2021 | Ashish Bhatia | Disposal | ₹159.00 | 5,231 | NSE |
20 Feb, 2021 | Ashish Bhatia | Disposal | ₹161.75 | 3,10,354 | NSE |
Corporate Actions
Announcement Date | Subject | Ex - Date | Record Date |
---|---|---|---|
23 May, 2024 | Rs.1.0000 per share(10%)Final Dividend | 24 Jul, 2024 | 24 Jul, 2024 |
24 May, 2023 | Rs.1.0000 per share(10%)Final Dividend | 20 Jul, 2023 | 20 Jul, 2023 |
Announcements
Date | Source | Detail |
---|---|---|
03 Apr, 2025 | NSE India | Fortis Healthcare Limited has informed the Exchange about Income Tax Order passed against the International Hospital Limited, an Indirect wholly owned subsidiary of the Company. |
03 Apr, 2025 | NSE India | Fortis Healthcare Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025. |
03 Apr, 2025 | BSE India | Please find enclosed certificate under Regulation 74(5) of SEBI (DP) regulations 2018. |
02 Apr, 2025 | BSE India | The relevant disclosure with respect to Fortis Trademarks and Allied Trademarks is attached |
02 Apr, 2025 | NSE India | Fortis Healthcare Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company |
02 Apr, 2025 | NSE India | Fortis Healthcare Limited has informed the Exchange regarding ''Regarding Fortis Trademarks And Allied Trademarks''. |
02 Apr, 2025 | BSE India | The relevant disclosure with respect to Fortis Trademarks and Allied Trademarks is attached. |
26 Mar, 2025 | NSE India | Fortis Healthcare Limited has informed the Exchange about Closure of Trading Window |
26 Mar, 2025 | NSE India | Fortis Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
21 Mar, 2025 | BSE India | The relevant disclosure is attached |
Board Meetings
Purpose | Details | Meeting Date | Broadcast Date |
---|---|---|---|
Quarterly Results | -- | 30 Jan, 2025 | 07 Feb, 2025 |
Quarterly Results | -- | 31 Oct, 2024 | 08 Nov, 2024 |
Others | Inter alia, to consider and approve the issue of Non-Convertible Debentures (NCD). | 07 Oct, 2024 | 09 Oct, 2024 |
To consider Fund Raising | -- | 30 Aug, 2024 | 30 Aug, 2024 |
Quarterly Results | -- | 31 Jul, 2024 | 06 Aug, 2024 |
Audited Results & Final Dividend | -- | 20 May, 2024 | 23 May, 2024 |
Quarterly Results | -- | 01 Feb, 2024 | 07 Feb, 2024 |
Quarterly Results | -- | 06 Nov, 2023 | 10 Nov, 2023 |
Quarterly Results | -- | 02 Aug, 2023 | 04 Aug, 2023 |
Audited Results & Final Dividend | -- | 17 May, 2023 | 23 May, 2023 |
Share Holding Pattern
Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
---|---|---|---|---|---|
Promoter Group | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
Foreign Institutions + | 26.77% | 23.72% | 31.01% | 30.08% | 36.83% |
Domestic Institutions + | 30.05% | 29.42% | 20.38% | 15.67% | 12.19% |
Government | 0% | 0% | 0% | 0% | 0% |
Public | 12.01% | 15.69% | 17.44% | 23.08% | 19.81% |
Others | 0% | 0% | 0% | 0% | 0% |
About Fortis Healthcare
Fortis Healthcare is a Public Limited Listed company incorporated on 28/02/1996 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L85110PB1996PLC045933 and registration number is 045933. Currently Company is involved in the business activities of Hospital activities. Company’s Total Operating Revenue is Rs. 1181.42 Cr. and Equity Capital is Rs. 754.96 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1996
Managing Director
Dr. Ashutosh Raghuvanshi
NSE Symbol
FORTIS
Fortis Healthcare Management
Name | Designation |
---|---|
Mr. Ravi Rajagopal | Chairperson & Independent Director |
Dr. Ashutosh Raghuvanshi | Managing Director & CEO |
Ms. Suvalaxmi Chakraborty | Independent Director |
Mr. Indrajit Banerjee | Independent Director |
Ms. Shailaja Chandra | Independent Director |
Mr. Tomo Nagahiro | Non Executive Director |
Mr. Dilip Kadambi | Non Executive Director |
Mr. Lim Tsin Lin | Non Executive Director |
Mr. Mehmet Ali Aydinlar | Non Executive Director |
Dr. Prem Kumar Nair | Non Executive Director |
Mr. Ashok Pandit | Non Executive Director |
Peer Comparison
Stocks | Market Cap | Market Price | 52 Week Low-High |
---|---|---|---|
Max Healthcare Institute | ₹1,10,595.74 | ₹1,137.65 ₹1,121.30(1.46%) | ₹743.000 - ₹1,227.500 |
Apollo Hospitals Enterprise | ₹96,544.93 | ₹6,714.55 ₹6,671.35(0.65%) | ₹5,690.800 - ₹7,545.100 |
Fortis Healthcare | ₹49,030.76 | ₹649.45 ₹659.70(-1.55%) | ₹406.350 - ₹744.000 |
Narayana Hrudayalaya | ₹34,280.50 | ₹1,677.45 ₹1,663.45(0.84%) | ₹1,087.800 - ₹1,725.000 |
Global Health | ₹33,149.05 | ₹1,234.20 ₹1,239.55(-0.43%) | ₹936.050 - ₹1,510.100 |
FAQs on Fortis Healthcare
What is the share price of Fortis Healthcare?
The share price of Fortis Healthcare on 04 Apr, 2025 is ₹ 649.45.
What is 52W high and 52W low share price of Fortis Healthcare?
The highest and lowest 52W share prices of Fortis Healthcare are ₹ 744.000 and ₹ 406.350
What is the market cap of Fortis Healthcare?
The market capitalization of Fortis Healthcare as of 04 Apr, 2025 is ₹ 49,030.76 Crores
What is the P/E ratio of Fortis Healthcare?
The current P/E ratio of Fortis Healthcare as of 04 Apr, 2025 is 96.77
What is the PB ratio of Fortis Healthcare?
The PB ratio of Fortis Healthcare as of 04 Apr, 2025 is 5.73
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)